1. Substance Abuse and Mental Health Services Administration.Key substance use and mental health indicators in the United States: results from the 2020 National Survey on Drug Use and Health (HHS Publication no. PEP21‐07‐01‐003 NSDUH Series H‐56). Rockville MD: Center for Behavioral Health Statistics and Quality Substance Abuse and Mental Health Services Administration;2021. Available at:https://www.samhsa.gov/data/sites/default/files/reports/rpt35325/NSDUHFFRPDFWHTMLFiles2020/2020NSDUHFFR1PDFW102121.pdf. Accessed 24 May 2022.
2. European Monitoring Center for Drugs and Alcohol Addiction. Infographic.Number of sterile syringes distributed per person who injects drugs and proportion of high‐risk opioid users in opioid agonist treatment (OAT). Available at:https://www.emcdda.europa.eu/media-library/infographic-number-sterile-syringes-distributed-person-who-injects-drugs-and-proportion-high-risk-opioid-users-opioid-agonist-treatment-oat_en(accessed 27 May 22).
3. Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review
4. Centers for Disease Control and Prevention.Drug Overdose. Death rates maps and graphs. Available at:https://www.cdc.gov/drugoverdose/deaths/index.html(accessed 2 June 22).
5. Population‐level impact of initiating pharmacotherapy and linking to care people with opioid use disorder at inpatient medically managed withdrawal programs: an effectiveness and cost‐effectiveness analysis